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Diquat (DQ) neurotoxicity mechanisms are unknown, although,
it's systemic toxicity is mediated by free radical reactions. The role of
glutathione cycle was assessed by glutathione reductase (GR) applied
in the pre-treatment of DQ poisoning. Wistar rats were used and tested
compounds were administered intrastriatally (i.s.) in one single dose.
Total glutathione (tGSH), glutathione disulfide (GSSG) and glutathione
peroxidase (GPx) were measured in the vulnerable brain regions
(VBRs) (striatum, hippocampus and cortex), at 30 minutes, 24 hours
and 7 days post treatment.
Results from the intact and the sham operated groups were not
statistically different. Rapid spatial spreading of oxidative stress was
confirmed in the examined VBRs..
Mortality (30-40%, within 24hrs) and signs of lethargy were
observed in the DQ group. Activity of GPx activity was elevated and
GSSG/GSH was higher in the examined VBRs during the experiment,
compared to the controls. The i.s. pre-treatment with GR achieved
neuroprotective role against DQ induced neurotoxicity, based on
animal survival, absence of lethargy and decreased GPx activity and
GSSG/GSH in the examined VBRs during the experiment, compared to
the DQ group. Our results confirmed that oxidation of GSH was the
reason for the reduced antioxidative defense against DQ neurotoxicity.
Key words: diquat, glutathione, glutathione disulfide, glutathione
peroxidase, glutathione reductase, neurotoxicity
INTRODUCTION
Misuse of pesticides, such as diquat (DQ) (1, 1'-dimethyl-4, 4'-bipyridinium),
can lead to excessive contamination of the environment. Diquat is extremely toxic
to humans (LD50 35 mg/kg) and animals (rats: LD50 is 110-150 mg/kg), by all
routes of exposure. Agriculture workers are professionally exposed to DQ by
inhalation and dermal route of administration. Target organs of DQ toxicity are GIT,
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liver and kidney (Stevens and Summer, 1991; Houzé et al., 1990; EXTOXNET
1993). It is known that DQ passes across the blood-brain barrier (Ku{i} et al.,
1974). Specific therapy of DQ poisoning has not been established to date, thus
symptomatic therapy is in use (Robbe III and Meggs, 2004). Clinical symptoms of
DQ poisoning are severe diarrhoea associated with disorders of water
metabolism; and as for central nervous system (CNS) effects, it was confirmed
that lethargy and general depression are the most commonly seen symptoms,
although some authors have reported tremors and convulsions (EXTOXNET,
1993). Mechanism of Dq neurotoxcity is not clarified until now. It was reported that
DQ passes the blood-brain barrier (BBB) (Ku{i} et al., 1974).
It is known that systemic toxicity of DQ is mediated by increased production
of free radicals, during its red-ox metabolism (Fuke et al., 1993; Wolfgang et al.,
1991). In the presence of cytochrome P-450 reductase, DQ2+ (dication salt is in a
commercial use) undergoes the one-electron reduction resulting in production of
its radical form, DQ•+ (stabilized by the conjugated double bond in the pyridine
ring and quaternary nitrogen in another ring). In the reaction of DQ•+ with
molecular oxygen (O2), superoxide anion radical (O2•–) and DQ2+ are formed,
subsequently generating a chain of free radicals reactions, which are recognized
as the main DQ cytotoxic effect (Fussella et al., 2011).
Brain tissue is particularly vulnerable to oxidative injury induced by red-ox
compound, such as DQ (Djukic et al., 2007). Some parts of the brain, including:
cortex, hippocampus and striatum are more vulnerable to oxidative/nitrosative
stress (OS/NS) (Jovanovic et al., 1997).
Glutathione (GSH) is the principal endogenous antioxidant. Reactions in
which GSH participates are reduction agent of lipid hydroperoxides and/or
hydrogen peroxides (H2O2), catalyzed by glutathione peroxidase (GPx);
conjugations of thiols, nitroso compounds and metal ions; and formation of
reactive thyil radicals (antioxidative, as well as, prooxidative nature of glutathione
analogue radical forms were established) (Dringen, 2000; Wu et al., 2004; Meister,
1988; Ballatori, 2009; Douglas, 1987; Leaver and George, 1998; Mieyal, 2008;
Smith, 2005; Kehrer, 1994). Depletion of GSH occurs in OS/NS. There is a growing
evidence that GSH plays an important role in the detoxification of reactive oxygen
species in OS related poisonings or diseases (Dringen, 2000; Chubatsua et al.,
1992; Ninkovic et al., 2003; Ninkovic et al., 2008).
In reactions of lipid hydroperoxides/H2O2 reduction by GPx, GSH (a donor
of reducing equivalents) becomes oxidized to glutathione disulfide (GSSG).
Several approaches have been undertaken to retain GSH at the level to achieve its
antioxidative effect, such as: a) systemic administration of precursors for the
biosynthesis of GSH (L-cysteine and/or N-acetylcysteine) which passes across
biological membranes and the BBB; and b) given orally, GSH is ineffective
because of its poor absorption from the digestive tract and/or poor ability to
permeate through the membrane (Zeevalk et al., 2008; Sommer et al., 2000;
Yoshimura et al., 1982). Recycling of GSSG back to GSH by glutathione reductase
(GR) is essential physiological reaction to maintain required amount of GSH for its
antioxidative role to be realised.
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Enzymes are large molecules that do not cross the BBB (Banks, 2009). In
order to examine the significance of GSH depletion at the expense of GSSG
formation in DQ neurotoxicity we administered GR intrastriataly (i.s.). In this
toxicological-experimental mechanistic study we tried: a) to ascertain what is the
role of glutathione cycle in DQ neurotoxcity; and b) to examine whether
neuroprotection of vulnerable brain regions (VBRs) (striatum, hippocampus and
cortex) against harmful oxidative injury of i.s. administered DQ would be achieved
by the i.s. pre-treatment with GR.
MATERIALS AND METHODS
Animals
The experimental animals were treated according to Guidelines for Animal
Study, No. 282-12/2002 (Ethics Committee of the Military Medical Academy,
Belgrade, Serbia and Montenegro). The experiments were performed on adult
male Wistar rats (~ 220g), randomly divided into two control groups (the intact
group n=8, and the sham-operated, n=24) and three experimental groups
(n=24, each) which were further subdivided into three subgroups (n=8)
according to the time of sacrificing. Conditions for rats housing: group of
rats/cage, t = 23_2 ºC, relative humidity 55 ± 3 %, a light/dark cycle: 13/11 hours,
and had free access to standard pellet food and water. Before the beginning of the
experiment, rats were adapted during 7 days.
Experimental design
Rats were anaesthetized intraperitoneally by sodium pentobarbital
(45 mg/kg per body weight) before the i.s administration of the testing
substances, as follows: the intact group (not treated, n=8), the sham-operated
rats (10 L of saline), n=24; the GR group(GR, 15.63 U/10 L), n=24; the DQ
group (2.5 g DQ /10 L, ie. 0.01 M/10 L) n=24; and the GR+DQ group (GR,
15.63 U/5 L, immediately before DQ administration, 0.01 M /5 L), n=24. Yeast
GR was used in this study according to homology with sequences of rats and
humans, substrate specificity, kinetics characteristic and substrate affinity
(Cardoso et al., 2008; Prado et al. 2004; Ondaraza and Abney, 1970; Lindsay,
1995). Testing substances were administrated by Hamilton syringe as single
doses in final volumes of 10 L, which is insufficient to burden nerve tissue. To
achieve accuracy of the testing substances injections we used a stereotaxic
instrument for small laboratory animals (coordinates: 8.4 mm behind the bregma,
2.6 mm left from the midline suture and 4.8mm ventral from dura) (König JFR,
1963). The animals were sacrificed by decapitation at 30 mins, 24 h and 7 days
after the treatments. Biochemical parameters of OS were measured in the ipsi-
and contra- lateral side of the VBRs. To exclude the possibility whether mechanical
injury causes OS in the VBRs, we compared OS parameters between the sham-
operated and the intact groups.
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Reagents
All chemicals were of analytical grade. The following compounds were used
in this study: Diquat – Galokson® (200 g/L) (Galenika – Zemun, Serbia); Sodium
pentobarbital – Vetanarcol® (0.162 g/mL) (Werfft – Chemie, Vienna, Austria);
Glutathione reductase (EC 1.6.4.2), Type III, from yeast Š9001-48-3¹, Sigma
Chemical Co (St Luis, MO, USA) – highly refined suspension in 3.6M (NH4)2SO4, at
pH 7.0; 2500 U/1.6 mL (9.2 mg prot/mL – biuret) 170 U/mg proteins (Note: 1 unit
reduces 1 mol GSSG/min, pH 7.6 at 25oC); saline solution (0.9% w/v) (Hospital
Pharmacy Military Medical Academy, Belgrade, Serbia); glutathione, glutathione
disulfide and nicotinamide adenine dinucleotide phosphate (NADPH)
(Boehringer Corp. – London, UK); ethylenediaminetetraacetic acid – EDTA, 2-
vinylpyridine (Sigma Aldrich - Sr. Louis, USA); sodium phosphate -Na2HPO4,
potassium dihydrogen phosphate - KH2PO4, 5,5-dithiobis-2-nitrobenzoic acid
(DTNB), triethanol amine, sulfosalicylic acid (Merck - Darmstadt, Germany);
Deionised water was prepared by the Millipore milli-Q water purification system
(Waters - Millipore, Milford, MA, USA).
The tissue preparation
The tissue homogenates of the VBRs were prepared as described earlier
(Gurd, 1974). After separation from the other brain regions, cortex, striatum and
hippocampus were kept on ice during the whole procedure. Slices of the VBRs
were transferred separately into cold buffered sucrose (0.25 mol/L sucrose,
0.1 mmol/L EDTA in sodium-potassium phosphate buffer, pH 7). Aliquots (1 mL)
were placed into a glass tube homogeniser (Tehnica Zelezniki Manufacturing,
Slovenia). Homogenization was performed twice with a teflon pestle at 800 rpm
(1,000 × g) for 15 min at 4oC. The supernatant was centrifuged at 2,500 × g for 30
min at 4oC. The resulting precipitate was suspended in 1.5 mL of deionised water.
Solubilisation of subcellular membranes in hypotonic solution was performed by
constant mixing for 1 h using a Pasteur pipette. Thereafter, homogenates were
centrifuged at 2,000 × g for 15 min at 4oC and the resulting supernatant was used
for analysis. Total protein concentration was estimated by Lowry method (Lowry et
al., 1951).
Measurements
Glutathione, total and oxidized disulfide form, and glutathione peroxidase
were measured in both sides of the striatum, hippocampus and cortex, after the
treatments at 30 min, 24 hrs and 7 days.
Total glutathione (tGSH) and oxidized glutathione (GSSG)
For determination of total glutathione (tGSH) and GSSG, brain tissue was
prepared in 10% sulfosalicylic acid. The tGSH and GSSG were then determined
before and after masking of the GSH content of the samples with 2-vinylpyridine
Šhomogenates were incubated with 1 M 2-vinylpyridine solution (10 L/mL of
homogenate) for two hours, at room temperature¹ and 3.4% triethanol amine to
mask GSH) followed by the enzymatic recycling assay by using 5,5-dithiobis-2-
nitrobenzoic acid (DTNB) (36.9 mg DTNB in 10 mL of methanol) which reacts with
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aliphatic thiol compounds in TRIS-HCl buffer (0.4 M, pH-8.9) and produces yellow
colour due to p-nitrophenol anion. Intensity of colour was measured
spectrophotometrically at 412 nm (Anderson, 1986; Mølck, Friis, 1997; Griffith,
1980; Shaik and Mehvar, 2006; Tretter et al., 2003). The results of tGSH and GSSG
were expressed as nmol per mg of proteins. The ratio GSSG/GSH was
considered for the interpretation of the results.
Glutathione peroxidase (GPx)
This method is based on the indirect determination of GPx activity by
spectrophotometric measurement of NADPH consumption at 340 nm. Briefly,
enzyme GPx catalyzes the reduction of (lipid) hydroperoxides to (alcohols)/H2O
using reducing equivalents of GSH, which itself then becomes oxidized.
Furthermore, regeneration of depleted GSH occurs throughout the reduction of
GSSG to GSH, catalyzed by the enzyme GR, which consumes NADPH as a donor
of reducing equivalents. Reduction of every mole of GSSG requires one mole of
NADPH (Maral et al., 1977). The results were expressed as U GPx per mg of
proteins.
Statistical analysis
Data analysis was performed using Statistica software version 7.0 (Stat Soft,
Inc.). Parameters of OS were presented graphically for the ispilateral and in
tabular form for the contralateral side of the VBRs. Data are shown as mean ±
standard deviation. Parameters of OS measured at different time points within
each group were compared by the independent Student's t-test. OS parameters
for the same time point, but between the groups, were compared using ANOVA
with the Tukey's post hoc test. Differences were considered statistically significant
when for p<0.05*, p<0.01** and p<0.001***.
RESULTS
The results obtained for the ipsilateral side of the VBRs (Graphs 1 – 4) were
almost identical to the contralateral side (data not shown). No statistical
differences were observed between the intact group and the sham-operated
groups. Lethality of the animals (30% - 40%) within 2-3 hours after awakening from
anesthesia was observed only in the DQ group. Lethargy was observed only in
that group, as well.
Total glutathione (tGSH), oxidised glutathione GSSG, reduced glutathione
(GSH) and ratio GSSG/GSH
Mainly, tGSH is calculated as: tGSH = GSH + GSSG, but some authors
calculate it differently, such as: tGSH=GSH+½ GSSG, although rarely; and/or
even as: tGSH = GSH+2 GSSG (Anderson, 1986; Griffith, 1980; Mølck and Friis,
1997; Shaik and Mehvar, 2006; Tretter et al., 2003). The ratio GSSG/GSH is
presented graphically (Graph 3).
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In the DQ group, the level of tGSH was in the range of control values. Only, in
the GR+DQ group, it was significantly lower in the examined VBRs, at 7th days
(p<0.05), compared to the controls (Graph 1).
Oxidized glutathione (GSSG) was statistically high in all VBRs during the
experiment in the DQ group (increase was the highest at 30th (striatum and cortex
p<0.01; hippocampus p<0.05), with descending trend over time (at 24th hrs:
striatum and cortex p<0.05; hippocampus p<0.01; and at 7 days: hippocampus
and cortex, p<0.05). In the GR+DQ group, concentration of GSSG was
statistically increased only in the cortex at 24th hrs. Compared to the DQ group,
values of GSSG were significantly different (lower), within 24 hrs in the examined
VBRs (p<0.05) (Graph 2).
The ratio GSSG/GSH was significantly higher in all VBRs during the
experiment in the DQ group emphasizing extremely high values within 24 hrs (for
the cortex, in particular) compared to the controls. In the GR+DQ group, values of
the ratio GSSG/GSH were still significantly higher in all VBRs during the
experiment, considering that at 30th min, those values are statistically lower
compared to the DQ group (Graph 3).
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Figure 1. Total glutathione (tGSH) in ipsilateral vulnerable brain regions (striatum,
hippocampus and cortex) of rats after single intrastriatal administration of diquat (the
DQ group), glutathione reductase (the GR group) and glutathione reductase in the
pretreatment of diquat administration (the GR + DQ group).
Presented parameter of antioxidative defence: Total glutathione (tGSH) is expressed
as: nmol tGSH/mg proteins. *See the experimental conditions presented in the
subsection: Experimental design. Values are means ± SD (n=8 rats per each time
point: 30 min, 24 hrs, 7 days).
One-way ANOVA followed by post-hoc Tukey test were used for statistical analysis;
p<0.05 was considered as significant for the same time point. Statistically significant
differences are marked as follows: p<0.05(*), p<0.01(**) and p<0.001(***) –
compared to the control group; and: p<0.05 (dq*), p<0.01 (dq**) and p<0.001
(dq***) – compared to the DQ group
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Figure 2. Glutathione disulfide (GSSG) in ipsilateral vulnerable brain regions (striatum,
hippocampus and cortex) of rats after single intrastriatal administration diquat (the
DQ group), glutathione reductase (the GR group) and glutathione reductase in the
pretreatment of diquat administration (the GR + DQ group).
Product of GSH oxidation, glutathione disulfide is expressed as: nmol GSSG/mg
proteins. *See the experimental conditions presented in the subsection:
Experimental design. Values are means ± SD (n=8 rats per each time point: 30 min,
24 hrs, 7 days).
One-way ANOVA followed by post-hoc Tukey test were used for statistical analysis;
p<0.05 was considered as significant for the same time point. Statistically significant
differences are marked as follows: p<0.05 (*), p<0.01 (**) and p<0.001 (***) –
compared to the control group; and: p<0.05 (dq*), p<0.01 (dq**) and p<0.001
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Figure 3. The ratio of GSSG/GSH calclulated for ipsilateral vulnerable brain regions
(striatum, hippocampus and cortex) of rats after single intrastriatal administration
diquat (the DQ group), glutathione reductase (the GR group) and glutathione
reductase in the pretreatment of diquat administration (the GR + DQ group).
The relation between oxidized and reduced glutathione is presented as the ratio
GSSG/GSH. The amount of reduced glutathione (GSH) was calculated by
subtracting GSSG from tGSH for each sample. *See the experimental conditions
presented in the subsection: Experimental design. Values are means ± SD (n=8 rats
per each time point: 30 min, 24 hrs, 7 days).
One-way ANOVA followed by post-hoc Tukey test were used for statistical analysis; p<0.05 was
considered as significant for the same time point. Statistically significant differences are marked as
follows: p<0.05 (*), p<0.01 (**) and p<0.001 (***) – compared to the control group; and: p<0.05
(dq*), p<0.01 (dq**) and p<0.001 (dq***) – compared to the DQ group.
Glutathione peroxidase (GPx)
In the DQ group, GPx activity was significantly increased in the examined
VBRs during the experiment (p<0.05). Contrary, in the GR+DQ group, GPx
activity was significantly reduced (p<0.05) and additionally, significantly lower
compared to the DQ group (p 0.05), within 24 hrs, and in the hippocampus, at 7
days (Graph 4).
DISCUSSION
For the first time, results of our study showed that i.s. administered GR,
given in the pre-treatment of DQ i.s. injection ascertained a neuroprotective role.
Specifically, in the group of rats i.s. poisoned with DQ, signs of lethargy and
mortality (30-40 %) after awakening from anesthesia, were observed within 24 hrs
of the treatment what was accompanied with initially (at the 30th min) huge
GSSG/GSH ratio and high activity of GPx. Though, with descending trend over
time, GSSG/GSH stayed significantly elevated during the experiment in the
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Figure 4. Activity of glutathione peroxidase (GPx) in ipsilateral vulnerable brain regions
(striatum, hippocampus and cortex) of rats after single intrastriatal administration
diquat (the DQ group), glutathione reductase (the GR group) and glutathione
reductase in the pretreatment of diquat administration (the GR + DQ group).
Presented parameter of antioxidative defense: Activity of GPx is expressed as: mU
GPx /mg proteins. *See the experimental conditions presented in the subsection:
Experimental design. Values are means ± SD (n=8 rats per each time point: 30 min,
24 hrs, 7 days).
One-way ANOVA followed by post-hoc Tukey test were used for statistical analysis; p
0.05 was considered as significant for the same time point. Statistically significant
differences are marked as follows: p<0.05(*), p<0.01(**) and p<0.001(***) –
compared to the control group; and: p<0.05 (dq*), p<0.01 (dq**) and p<0.001
(dq***) – compared to the DQ group
examined VBRs in the DQ group. Contrary to that, in the GR+DQ group, all
animals survived and there were no sings of lethargy Additionally, biochemical
parameters of glutathione cycle showed that GSSG was in the range of controls
but statistically lower compared to DQ group within 24 hrs (p<0.05) as it was seen
for GPX, with the difference that latter was significantly lower compared to the
controls in all time points (except for the striatum at 30th min and 7th days, and
hippocampus, at 7th days). It was obvious that the pre-treatment with GR,
weakened the DQ harmful effect on the examined brain regions (Graphs 1-4). It is
still unknown the mechanism underlying these confirmed changes.
Results obtained from the intact and the sham operated groups were not
statistically different, confirming that invasive i.s. route of administration does not
influence the reliability of results. Also, a similar pattern of changes was observed
within the examined VBRs, indicating fast spatial spreading of OS. By analogy
with the studies of Corsanti, Beggeta and co-workers who reported about PQ
nurotoxicity we designed our experiment to study the pathways of DQ
neurotixicity (Widdowson et al., 1996). In our experiment, we injected i.s a dose of
DQ (0.01 mol/10 L) to Wistar rats. Apparently, the applied dose was satisfactory
to study the mechanisms of DQ neurotoxicity. Seven days is a period sufficient for
recovery to be achieved, if reversible tissue damage occurred (Kang, 2009;
McCormack et al., 2005; Widdowson et al., 1996).
Our results and observations showed that remarkable high GPx activity
along with a huge peak of the ratio GSSG/GSH (within 30 mins of DQ i.s.
administration) coincided with signs of lethargy and animals death (within 24 hrs
of i.s. administration of DQ) and is associated with significant oxidation of GSH
(Graphs 1-4) (Elsayed, 1982). That could be explained by the DQ cytotoxic effect,
ie. powerful oxidative metabolism of DQ and consequent enormous O2
deprivation. Compared to paraquat (PQ) (widely used herbicide, bipyridylium
analogue of DQ), DQ is a more powerful oxidant based on its redox potentials
(Eo'=-349 mV for DQ and Eo'=-446 mV for PQ) and its intense oxidative
metabolism probably underlies its harmful effects (Lewinson et al., 1984).
Explicitly, DQ•+ reacts with O2, forming O2•– and DQ2+, thus triggers free radicals
chain reactions and development of OS/NS, what was proofed by our previous
study (submitted, but still not published data) (Grushenka et al., 1991; Fussella et
al., 2011). Instantly launched antioxidative mechanisms were recognized with
increased GPx activity and therefore a marked increase of GSSG, although tGSH
was not significantly decreased at the time. It is known that in physiological
conditions the extent of GSSG is neglected compared to GSH (Olafsdottir and
Reed, 1988). Thus, for example in mitochondria, the ratio of GSSG/GSH (1:10)
indicates a powerful oxidative metabolism in this cell compartment, which is also
assembled with more intense GSH red-ox turnover than in the cytosol. Therefore,
more intense oxidative metabolism requires more increased antioxidant
protection (Richman and Meister, 1975). As mitochondria lack the enzymes for
GSH synthesis, the mitochondrial GSH concentration is maintained constant via
uptake from the cytosol (transport systems, which are stimulated by ATP and and
ADP (Pastore et al., 2003). Cellular synthesis and consumption of GSH are
balanced by its synthesizes (ATP dependent two-steps synthesis: the gGluCys
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synthetase uses glutamate and cysteine to form the dipeptide gGluCys, which is
further combined with glycine in a reaction catalyzed by glutathione synthetase to
generate GSH) and feedback inhibition of gGluCys synthetase by the end-
product GSH, at the intracellular level (Richman and Meister, 1975; Olafsdotti et al,
1988; Dringen, 2000).
Based on extremely increased peak of the GSSG/GSH at 30th min of DQ i.s.
poisoning (Graph 3), our study confirms that the GSH oxidation to GSSG is the
dominant way of GSH depletion in DQ neurotoxicity comparing to the other
pathways of GSH depletion such as conjugation with proteins, NO, metals, etc.
(Pastore et al., 2003). Steady state concentrations of O2•– and DQ2+ interfere the
metabolism of glutathione forms such as: thiyl radical (GS•), thiolate anion (GS–)
and conjugate of thiyl radical and thiolate ŠGSSG¹•–. Redox compounds, which
radical forms are stabilized by the conjugated double bond, such as
semiquinones ŠQ2•–/Q2–¹ and bipyridilium compounds ŠDQ2+/DQ•+¹, could be
involved in the oxidation of GS– oxidation to GS• (Fukushima et al., 1994; Nivière
and Fontecave, 1955; Cadenas 1997). In the presence of O2•– and DQ2+,
oxidation of GS– to GS• could take two possible pathways: a) when ŠDQ2+¹ss or
ŠQ2•–¹ss >>ŠO2•–¹ss, enzyme SOD favours oxidation of GS– to GS•; b) if ŠDQ2+¹ss
or ŠQ2•–¹ss<ŠO2•–¹ss, then GS• formation is suppressed by SOD. Also, when
ŠDQ2+¹ss or ŠQ2•–¹ss >> ŠO2•–¹ss, enzyme SOD favors conjugation of thiyl radical
with thiolate (RS•+RS– = ŠGSSG¹•–) and oxidation of ŠGSSG¹•– to GSSG
(ŠGSSG¹•– + O2 = GSSG + O2•–). Therefore, relative steady state concentrations
of O2. and DQ2+ have an influence on cell red-ox state. These facts are also
confirmed by the results referring to the high GSSG/GSH ratio in the DQ group
(Graphs 3).
Thiyl radical enhances the lipid peroxidation because of its strong red-ox
potential (Eo'RS•/RSH=+0.9 V) and easily reacts with free fatty acids: a) abstraction
of hydrogen (rate of reaction is ¬ 107 M-1s-1), b) addition to double bonds (rate of
reaction is ¬108 M-1s-1), when formed alkyl radical may react with O2 to form
corresponding peroxyl radicals (Schafer, 2001). Obviously, depleted GSH and
consequently reduced antioxidative defense is and was probably the crucial
factor, besides O2 deprivation, for harmful outcome of DQ i.s. poisoning of rats
(Boonplueang, 2005). Importance of glutathione cycle in DQ neurotoxicity and its
neuroprotective role is confirmed in our study by i.s. applying of GR.
Descending trend of GPx activity and decreasing of GSSG over time in the
DQ group, emphasize that the most deleterious effects occur immediately upon
exposure to DQ, within 24 hrs, during immense red-ox metabolism of DQ that
coincided with lethargy and mortality of animals. Biochemical parameters of
antioxidative defense, such as GPx and GSSG/GSH, were recognized as very
sensitive and the most responsive OS biomarkers of DQ induced neurotoxicity.
Mammalian cells can deal with an increased GSSG/GSH ratio in several
ways: synthesis of more GSH (using g-GCS), convertion of GSSG into GSH
(using GR) or export of GSSG (Schafer, 2001). It is not known, what is the
proportion between comprised elements of total thiols (refers to free glutathione
forms: GSH and GSSG, and protein and/or NO-bound fractions) (Pastore et al.,
2003). Positive outcome of i.s. administration of GR in the pre-treatment of DQ i.s.
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poisoning, suggests the possibility that GSSG reduction occurs extracellularly,
although it is known that it occurs within the cell, emphasizing that the fraction of
"free" GSSG is considerable compared to total glutathione (Olafsdottir and Reed,
1988). Within this context, reduction of "free" GSSG back to GSH by GR deserves
noteworthy attention, in sense that reduction by GR could prevent its conjugation
with proteins, lipids, NO, metals, etc, and thus avoid/minimize damage of cells/
tissues.
Also, DQ neurotoxicity could be attributed to the formation of GS-NO
(reaction of nucleophilic addition of GSH to substrate that have electrophilic
functional group), catalyzed by GSH-S-transferase, which also explains the
decrease of GPx activity (that uses GSH as a donor of reducing equivalents)
(Noack H et al., 1999). Donors of NO could decrease intracellular glutathione
(GSH) levels in lymphocytes by as much as 75% (Berendji et al., 1999). Changed
thiol–disulfide status of critical cysteines on enzymes, receptors, transport
proteins, and transcription factors is recognized as an important mechanism of
signal transduction and an important consequence of OS associated diseases
(Mieyal et al., 2008). Additionally, GSSG directly activates N-methyl D-aspartate
(NMDA) receptors and/or enhances its response, by which excitotoxicity
becomes part of the overall response to DQ i.s. exposure (Boonplueang et al.,
2005). Thus both, increased GPx activity followed by subsequent GSSG increase
(significantly elevated GSSG/GSH within 24 hrs) possibly contribute to
excitotoxicity via stimulation of NMDA receptors and subsequent release of
glutamate, which coincided with rats mortality in the DQ group.
According to our previous study (submitted, but not published yet) DQ
neurotoxicity is mediated by OS/NS. Ebadi and Sharma's showed (2003) that
peroxynitrite anion (ONOO–) effectively inhibits enzymes in the mitochondrial
respiratory chain followed by reduced ATP synthesis (Djukic et al., 2007; Ebadi
and Sharma, 2003; Lestaevel et al., 2003). It is known that depletion of the sources
of electrons and H+ donors, such as NADPH and GSH, happens during OS/NS.
Depletion of NADPH and activation of the hexose monophosphate shunt (HMPS),
increased production of reactive oxygen specie's and oxidation of GSH to GSSG
altogether contribute to DQ cytotoxic effect and energy exhaustion eventually led
to cell death (Tawara, 1996). Some redox-cycling compounds completely inhibit
the activation of HMPS by inhibiting GR (Schraufstatter et al., 1985). However,
there is no data specifically related to the inhibition of GR by DQ, but if we presume
that it is possible, we can speculate that the GR pre-treatment procedure adopted
by us could be one rationale more, for such experimental approach.
Almost equal values of OS parameters in the VBRs proved prompt and
spatial spreading of oxidative deleterious effects of DQ (Cui et al., 2004; Halliwell,
2001). Primary damage to one part of brain tissue inevitably leads to subsequent
disorders in other structures, as confirmed by our experiments. The anatomical-
functional organization of these brain structures underlying equal propagation
process of OS (Fukushima et al., 1994; Tawara et al., 1996). No significant
variations of GSH levels between brain regions (cortex, hippocampus, striatum,
midbrain, and cerebellum) were reported, although in here we reported the
sequence by the amount of GSH level as follows: hippocampus>striatum>cortex
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in intact rats (differences were statistically insignificant), while there are some
reports that slightly higher values of GHS were found in the cortex (Rou{ar et al.,
2012). Although, striatum was the brain region that was targeted by i.s. injection of
the testing substances in our experiment, the obtained results showed that red-ox
balance was not significantly changed in this structure (sham operated vs. intact
group).
Intrastriatal administration of GR itself does not exert any harmful effect
(Graphs 1-4). Taking into consideration the above facts, it becomes obvious that
tissues of the VBRs were protected by GR pre-treatment, most likely due to
recycling of GSSG back to GSH (Graphs 1 - 4). It was shown that the antioxidative
effect of GSH is crucial in neuro-protection of brain tissues against harmful effect
of DQ mediated by OS/NS. The oxidation of GSH to GSSG is probably dominant
way of GHS depletion in DQ induced neurotoxicity and main reason for reduced
antioxidative defense against DQ harmful oxidative effect. Guided by the fact that
GR does not pass across the cell membrane and/or the blood-brain barrier and
further, we applied i.s. GR to enable extracellular/interstitial conversion of GSSG
into the GSH. The mechanisms of GSH and/or its precursors or breakdown
products transport of across the membranes and/or the blood-brain barrier is still
unrevealed (Wade and Brady, 1981; Ennis et al., 1998; Kannan et al., 1990; 1992;
1996; 1999; Zlokovic et al., 1994; Favilli et al., 1997; Jain et al., 1991; Meister,
1991). Our study confirms that extracellularly recycled GSSG by GR, i.s.
administered, contributes to increasing reuptake of GSH (tripeptide: -L-glutamyl-
L-cysteinyl glycine) or its precursors or breakdown constituents (structure
constituents: amino-acids in single or di-peptide form) into the cells of CNS, thus
achieving the protective role.
CONCLUSION
In summary, GSH – mediated antioxidative response and oxygen starvation
are probably critical pathophysiological pathways in an early stage of DQ i.s.
induced neurotoxicity. The absence of lethargy and mortality in the group of rats
pre-treated with GR indicated a neuroprotective role of i.s. administered GR.
Results of this study firstly indicate that the pre-treatment of i.s. injected GR
accomplished the protective role against harmful i.s. DQ poisoning, probably due
to extracellularly/interstitially GSSG recycling and sustaining of GSH at the level
essential for its antioxidative role (by cell reuptake of extracellularly formed GSH–
catalyzed reaction by i.s. injected GR). Our findings are very important and
valuable in the scientific field of thiol-based redox regulation and signaling.
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ULOGA GLUTATIONSKOG CIKLUSA U NEUROTOKSI^NOSTI DIKVATA:
ISPITIVANO PIRMENOM INTRASTRIJATALNOG PREDTRETMANA SA
GLUTATION REDUKTAZOM
\UR\EVIC D, \UKI] MIRJANA, NINKOVI] MILICA, STEVANOVI] IVANA, JOVANOVI]
MARINA i VASI] UNA
SADR@AJ
Mehanizmi neurotoksi~nosti dikvata (DK) su nepoznati, mada se zna da je
sistemska toksi~nost posredovana reakcijama slobodnih radikala. Uloga gluta-
tionskog ciklusa je isptivana primenom glutation reduktaze (GR) u predtretmanu
trovanja DK. Wistar pacovi su kori{}eni i testirana jedinjenja intrastrjiatalno (i.s.)
primenjena u jednokratnoj dozi. Ukupni glutation (tGSH), glutation-disulfid
(GSSG) i aktivnost glutation peroksidaze (GPx) su mereni u selektivno osetljivim
regionima mozga (strijatum, hipokampus i korteks), 30. minuta, 24. sata i 7. dana
posle tretmana.
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Rezultati netretiranih (intaktna grupa) i la`no operisanih pacova se ne
razlikuju statisti~ki. Vremensko i prostorno {irenje oksidativnog stresa je po-
tvr|eno kod ispitivanih mo`danih struktura. Mortalitet (30-40%, u roku od 24 ~asa)
i znaci letargije su uo~eni u samo u DK grupi. Statisti~ki pove}ana aktivnost GPx,
kao i odnosa GSSG/GSH u ispitivanim mo`danim strukturama tokom eksperi-
menta, potvr|uje oksidativno naru{enu ravnote`u i o{te}enja mo`danog tkiva.
Predtretman i.s. sa GR je ispoljio neuroza{titni efekat od neurotoksi~nosti DK, ba-
zirano na pre`ivljavanju `ivotinja, odsustvu letargije i smanjenoj aktivnost GPx i
odnosa GSSG / GSH ispitivanih mo`danih struktura tokom eksperimenta, u od-
nosu na DK grupu. Na{i rezultati ukazuju da je oksidacija GSH klju~na za sma-
njenje antioksidativne odbrane od DK neurotoksi~nosti.
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